1013 News Items found

Early Drug Approvals Can Backfire

Medical oncologist Clifford Hudis discussed a new study that suggests more cancer agents of questionable benefit remain on the market....

  • Tuesday, October 20, 2015
  • The Boston Globe

The Connection Between Cancer Treatment and Cardiac Problems

Cardiologist Richard Steingart was inteviewed about "cardio-oncology" clinics for cancer patients. ...

  • Tuesday, October 20, 2015
  • U.S News & World

The Exceptional: What Miraculous Recoveries Can Teach Us About Beating Cancer

Physician-scientist David Solit discusses what it means to be an "exceptional responder" in Popular Mechanics.   ...

  • Saturday, October 17, 2015
  • Popular Mechanics

Why Are Life-Saving Drugs So Expensive?

Epidemiologist Peter Bach discusses drug prices on The Leonard Lopate Show. ...

  • Saturday, October 17, 2015
  • W-NYC The Leonard Lopate Show

Is It Possible to Have Too Much Info About Breast Cancer?

Cancer geneticist Kenneth Offit discusses genetic testing and understanding cancer risk in Allure Magazine. ...

  • Friday, October 16, 2015
  • Allure Magazine

Should We Bank Our Own Stool?

Physician-scientist Eric Pamer discussed fecal transplants and their efficacy in The New York Times....

  • Sunday, October 11, 2015
  • The New York Times

U.S. Cancer Doctors Drop Pricey Drugs with Little or No Effect

Epidemiologist Peter Bach and medical oncologist Leonard Saltz discuss the price of cancer drugs. ...

  • Thursday, October 8, 2015
  • Reuters

Three Newly Appointed MacArthur 'Geniuses'

Developmental biologist Lorenz Studer was interviewed on his research which could provide treatment for Parkinson’s disease....

  • Thursday, October 8, 2015
  • W-NYC The Leonard Lopate Show

Ask a MacArthur Genius: Can Transplanted Brain Cells Cure Parkinson’s?

Developmental biologist Lorenz Studer discusses Parkinson’s disease....

  • Monday, October 5, 2015
  • Washington Post

FDA Approves Bristol-Myers’s Yervoy, Opdivo for Treatment of Melanoma

Immunologist Jedd Wolchok was interviewed about the U.S. Food and Drug Administration approving the first therapy combining two cutting-edge...

  • Friday, October 2, 2015
  • The Wall Street Journal